Alan Allman Associates (EPA:AAA)
France · Delayed Price · Currency is EUR 4.000
-0.050 (-1.23%)
Aug 13, 2025, 5:29 PM CET
Ligand Pharmaceuticals Market Cap
Alan Allman Associates has a market cap or net worth of €182.14 million as of August 13, 2025. Its market cap has decreased by -46.86% in one year.
Market Cap
182.14M
Enterprise Value
357.36M
Revenue
374.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.00
Market Cap Chart
Since April 8, 2021, Alan Allman Associates's market cap has decreased from 186.11M to 182.14M, a decrease of -2.14%. That is a compound annual growth rate of -0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 184.41M | -18.73% |
| Dec 31, 2024 | 226.91M | -54.04% |
| Dec 29, 2023 | 493.74M | 25.43% |
| Dec 30, 2022 | 393.62M | -29.78% |
| Dec 31, 2021 | 560.55M | 201.19% |
| Apr 8, 2021 | 186.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Airbus SE | 139.11B |
| Schneider Electric S.E. | 123.15B |
| Safran | 120.33B |
| Vinci | 67.50B |
| Compagnie de Saint-Gobain | 47.93B |
| Thales | 46.89B |
| Legrand | 33.91B |
| Veolia Environnement | 21.48B |